BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Windward Bio readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies Windward Bio's drugs run\, from C
 linicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07646587-1536@assetmemo.bio
DTSTAMP:20261121T005811Z
DTSTART;VALUE=DATE:20271217
DTEND;VALUE=DATE:20271218
SUMMARY:WIN378: Phase 2 readout est. (NCT07646587)
DESCRIPTION:WIN378\, phase 2\, Chronic Obstructive Pulmonary Disease.\nStud
 y: A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
 \nEstimated primary completion: 17 December 2027. This is a ClinicalTrials
 .gov estimate\, not a confirmed readout date\, and it can move.\nDrug page
 : https://assetmemo.bio/drug/win378#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT07646587
URL:https://assetmemo.bio/drug/win378#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07120503-1536@assetmemo.bio
DTSTAMP:20261121T005811Z
DTSTART;VALUE=DATE:20281001
DTEND;VALUE=DATE:20281002
SUMMARY:WIN378: Phase 2 readout est. (NCT07120503)
DESCRIPTION:WIN378\, phase 2\, Asthma.\nStudy: Study to Evaluate the Safety
 \, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe A
 sthma\nEstimated primary completion: 1 October 2028. This is a ClinicalTri
 als.gov estimate\, not a confirmed readout date\, and it can move.\nDrug p
 age: https://assetmemo.bio/drug/win378#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07120503
URL:https://assetmemo.bio/drug/win378#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
